Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1293-1302

  Brockschmidt, F F ^a   Heilmann, S ^a   Ellis, J A ^b,c   Eigelshoven, S ^d   Hanneken, S ^d   Herold, C ^a   Moebus, S ^e   Alblas, M A ^a   Lippke, B ^a   Kluck, N ^a   Priebe, L ^a   Degenhardt, F A ^a   Jamra, R A ^f   Meesters, C ^a,g   Jockel K H ^e   Erbel, R ^h   Harrap, S ^b   Schumacher, J ^a   Frohlich H ⁱ   Kruse, R ^j   Hillmer, A M ^k   Becker, T ^a,g   Nothen M M ^a   more..

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^h UNIVERSITY HOSPITAL ESSEN   (Germany)

ⁱ Rheinische Friedrich Wilhelms Universität   (Germany)

^j Private Dermatology Practice   (Germany)

^k GENOME INSTITUTE OF SINGAPORE   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HISTONE DEACETYLASE; HISTONE DEACETYLASE 9; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ALOPECIA; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CHROMOSOME 7P; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOME; GERMANY; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALOPECIA; ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 7; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISTONE DEACETYLASES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS;

EID: 82255164070     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10708.x     Document Type: Article

References (41)

1. Hamilton JB,. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951; 53: 708-28.
2. Hamilton JB,. Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anat 1942; 71: 451-80.
3. Nyholt DR, Gillespie NA, Heath AC, et al. Genetic basis of male pattern baldness. J Invest Dermatol 2003; 121: 1561-4. (Pubitemid 38005516)
4. Brockschmidt FF, Hillmer AM, Eigelshoven S, et al. Fine mapping of the human AR/EDA2R locus in androgenetic alopecia. Br J Dermatol 2010; 162: 899-903.
5. Ellis JA, Stebbing M, Harrap SB,. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 2001; 116: 452-5. (Pubitemid 32202911)
6. Hayes VM, Severi G, Eggleton SA, et al. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 2005; 14: 993-6. (Pubitemid 40478569)
7. Hillmer AM, Brockschmidt FF, Hanneken S, et al. Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 2008; 40: 1279-81.
8. Hillmer AM, Flaquer A, Hanneken S, et al. Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Am J Hum Genet 2008; 82: 737-43.
9. Hillmer AM, Hanneken S, Ritzmann S, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 2005; 77: 140-8. (Pubitemid 40848045)
10. Levy-Nissenbaum E, Bar-Natan M, Frydman M, et al. Confirmation of the association between male pattern baldness and the androgen receptor gene. Eur J Dermatol 2005; 15: 339-40. (Pubitemid 41337408)
11. Prodi DA, Pirastu N, Maninchedda G, et al. EDA2R is associated with androgenetic alopecia. J Invest Dermatol 2008; 128: 2268-70.
12. Richards JB, Yuan X, Geller F, et al. Male-pattern baldness susceptibility locus at 20p11. Nat Genet 2008; 40: 1282-4.
13. Sawaya ME, Shalita AR,. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 1998; 3: 9-15. (Pubitemid 28352163)
14. Norwood OT,. Male pattern baldness: classification and incidence. South Med J 1975; 68: 1359-65.
15. Miller SA, Dykes DD, Polesky HF,. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
16. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5. (Pubitemid 40202029)
17. Herold C, Steffens M, Brockschmidt FF, et al. INTERSNP: genome-wide interaction analysis guided by a priori information. Bioinformatics 2009; 25: 3275-81.
18. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75. (Pubitemid 47330214)
19. Cordell HJ, Clayton DG,. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-41. (Pubitemid 34031703)
20. Herold C, Becker T,. Genetic association analysis with FAMHAP: a major program update. Bioinformatics 2009; 25: 134-6.
21. Spielman RS, McGinnis RE, Ewens WJ,. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16. (Pubitemid 23311321)
22. Becker T, Knapp M,. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 2004; 75: 561-70. (Pubitemid 39244771)
23. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-8. (Pubitemid 34164012)
24. Cerami EG, Gross BE, Demir E, et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res 2011; 39: D685-90.
25. Petrie K, Guidez F, Howell L, et al. The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem 2003; 278: 16059-72. (Pubitemid 36799727)
26. Zhou X, Marks PA, Rifkind RA, et al. Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci USA 2001; 98: 10572-7. (Pubitemid 32878662)
27. Yang XJ, Gregoire S,. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol 2005; 25: 2873-84. (Pubitemid 40464294)
28. de Ruijter AJ, van Gennip AH, Caron HN, et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370: 737-49. (Pubitemid 36399066)
29. Fu M, Wang C, Zhang X, et al. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 2004; 68: 1199-208. (Pubitemid 39094285)
30. Haberland M, Montgomery RL, Olson EN,. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009; 10: 32-42.
31. Ruthenburg AJ, Li H, Patel DJ, et al. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 2007; 8: 983-94. (Pubitemid 350174643)
32. Parra M, Verdin E,. Regulatory signal transduction pathways for class IIa histone deacetylases. Curr Opin Pharmacol 2010; 10: 454-60.
33. Martin M, Kettmann R, Dequiedt F,. Class IIa histone deacetylases: regulating the regulators. Oncogene 2007; 26: 5450-67. (Pubitemid 47255927)
34. Haberland M, Arnold MA, McAnally J, et al. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol Cell Biol 2007; 27: 518-25. (Pubitemid 46080121)
35. Wyce A, Bai Y, Nagpal S, Thompson CC,. Research resource: the androgen receptor modulates expression of genes with critical roles in muscle development and function. Mol Endocrinol 2010; 24: 1665-74.
36. Ellis JA, Sinclair R, Harrap SB,. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 2002; 4: 1-11.
37. Hibberts NA, Howell AE, Randall VA,. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998; 156: 59-65. (Pubitemid 28049864)
38. Kligman AM,. The human hair cycle. J Invest Dermatol 1959; 33: 307-16.
39. Sinclair R,. Male pattern androgenetic alopecia. BMJ 1998; 317: 865-9.
40. Courtois M, Loussouarn G, Hourseau C, et al. Hair cycle and alopecia. Skin Pharmacol 1994; 7: 84-9. (Pubitemid 24086198)
41. Kaufman KD,. Androgens and alopecia. Mol Cell Endocrinol 2002; 198: 89-95. (Pubitemid 36169938)